Citigroup Inc Bluebird Bio, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Citigroup Inc holds 143,334 shares of BLUE stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

143,334

Previous 48,506 195.5%

Holding current value

$1.32 Million

Previous $47,000 57.45%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.47 - $1.35 $44,569 - $128,017	94,828 Added 195.5%	143,334 $74,000
Q2 2024 Aug 12, 2024	BUY	$0.85 - $1.26 $192 - $286	227 Added 0.47%	48,506 $47,000
Q1 2024 May 10, 2024	SELL	$0.91 - $1.75 $441,368 - $848,785	-485,020 Reduced 90.95%	48,279 $61,000
Q4 2023 Feb 09, 2024	SELL	$1.32 - $4.83 $32,564 - $119,156	-24,670 Reduced 4.42%	533,299 $735,000
Q3 2023 Nov 09, 2023	BUY	$3.02 - $4.05 $92,206 - $123,654	30,532 Added 5.79%	557,969 $1.7 Million
Q2 2023 Aug 10, 2023	SELL	$2.79 - $5.03 $2.21 Million - $3.98 Million	-791,731 Reduced 60.02%	527,437 $1.74 Million
Q1 2023 May 11, 2023	BUY	$3.14 - $8.22 $2.63 Million - $6.87 Million	836,097 Added 173.08%	1,319,168 $4.19 Million
Q4 2022 Feb 09, 2023	SELL	$5.77 - $8.49 $2.28 Million - $3.36 Million	-395,337 Reduced 45.01%	483,071 $3.34 Million
Q3 2022 Nov 10, 2022	BUY	$3.75 - $7.39 $3.25 Million - $6.4 Million	866,292 Added 7149.98%	878,408 $5.56 Million
Q2 2022 Aug 10, 2022	SELL	$2.94 - $5.23 $521,500 - $927,702	-177,381 Reduced 93.61%	12,116 $50,000
Q1 2022 May 12, 2022	SELL	$4.07 - $10.6 $1.29 Million - $3.37 Million	-317,961 Reduced 62.66%	189,497 $919,000
Q4 2021 Feb 10, 2022	BUY	$8.96 - $16.31 $3.21 Million - $5.85 Million	358,494 Added 240.66%	507,458 $5.07 Million
Q3 2021 Nov 10, 2021	BUY	$11.24 - $21.0 $1.67 Million - $3.13 Million	148,964 New	148,964 $2.85 Million

Others Institutions Holding BLUE

# of Institutions

150

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $708M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account